Perspectives on the mitochondrial permeability transition  by Bernardi, Paolo et al.
ELSEVIER Biochimica et Biophysica Acta, 1365 (1998) 200-206 
B1OCHIMICA ET BIOPHYSICA ACTA BB I 
Perspectives on the mitochondrial permeability transition 
Paolo Bernardi a'b'*, Emy Basso b, Raffaele Colonna 'b, Paola Costantini b, Fabio Di Lisa a'c, 
Ove Eriksson b, Eric Fontaine b, Michael Forte s, Franqois Ichas b, Stefano Massari a'b, 
Annamaria Nicolli b'd, Valeria Petronilli a, Luca Scorrano b 
aC.N.R. Unit for the Study of Biomembranes, Viale G. Colombo 3, 1-35121 Padua, Italy 
bDepartment ofBiomedical Sciences, University of Padua, 1-35121 Padua, Italy 
CDepartment ofBiological Chemistry, University of Padua, 1-35121 Padua, Italy 
dVollum Institute, Oregon Health Sciences University, Portland OR 97201, USA 
Received 27 January 1998; received in revised form 16 March 1998; accepted 16 March 1998 
Abstract 
The permeability transition, a sudden permeability increase of the inner mitochondrial membrane that is greatly favored 
by Ca 2+ accumulation, has puzzled mitochondrial scientists for more than 40 years. It is now recognized that this 
phenomenon is mediated by opening a high conductance channel (the mitochondrial permeability transition pore) whose 
open-closed transitions are highly regulated. Through the pore mitochondria may participate in intracellular signalling, and 
release proteins involved in amplification of the cell death cascade triggered by a variety of physiological and pathological 
stimuli. Yet, the basic questions of the molecular nature of the permeability transition pore, its physiological role and its very 
occurrence in vivo remain a matter of intense debate. This short review is meant o summarize our current views on the 
mitochondrial permeability transition, its perspectives, and our strategies to resolve at least some of the outstanding issues 
about its nature and function. © 1998 Elsevier Science B.V. 
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1. Introduction 
The 'permeability ransition' can be defined as a 
generalized increase of permeability of the mito- 
chondrial inner membrane, which leads to membrane 
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depolarization, substrate depletion, and equilibration 
of species with molecular weight (MW)~1500 Da or 
lower resulting in matrix swelling and rupture of the 
outer membrane [1-5]. This phenomenon is easily 
observed after Ca 2+ accumulation, or simply as a 
consequence of in vitro aging of mitochondria. 
Because of the lack of selectivity of the permeability 
pathway(s), the permeability ransition has long been 
considered as an unspecific form of membrane dam- 
age. This attitude has rapidly changed with the 
recognition that the permeability transition is me- 
diated by opening of a high conductance hannel, the 
mitochondrial permeability ransition pore (MTP) [6- 
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8]. The MTP is a highly regulated system, which may 
provide mitochondria with a fast Ca 2+ release chan- 
nel [4]. Recent evidence indeed indicates that tran- 
sient MTP openings in a low conductance mode (i.e. 
a state permeable to ions but not to larger molecules 
such as sucrose) may contribute to physiological 
Ca 2+ signalling through amplification of IP3-depen- 
dent Ca 2+ release [9]. 
MTP opening in a high conductance mode appears 
to be involved in many forms of cell injury, including 
ischemia-reperfusion, oxidative stress and that 
caused by toxic compounds [1-5] and in pro- 
grammed cell death through release of a specific 
caspase [10]. It is noteworthy that the permeability 
transition is also an attractive mechanism for the 
release of cytochrome c, which is instrumental in a 
variety of models of cell death [11,12], and a 
potential target for regulation by the members of the 
bcl-2 superfamily [13] (also, see Refs. [14,15] for 
reviews). Thus, both understanding MTP function 
and regulation in vivo, and development of novel 
tools of intervention is going to have a major impact 
on vital cellular processes. Here, we summarize our 
views on the mitochondrial permeability transition, 
its perspectives, and our strategies to resolve some of 
the outstanding issues about its nature and function. 
A thorough coverage of this field can be found in the 
Biochimica et Biophysica Acta Bioenergetics Special 
Issue, Mitochondria in Cell Death (1998). 
2. Nature of the permeability transition 
Patch-clamp studies of mitoplasts have identified a
high conductance channel, the mitochondrial 
megachannel [16,17] that responds to a variety of 
inhibitors and activators in the same way as does the 
permeability transition in isolated mitochondria [6- 
8]. These findings indicate that the megachannel and 
the MTP may be structurally identical, and that the 
permeability transition is a channel-mediated event. 
Its molecular nature, however, remains elusive. 
Based on the inhibitory effect of bongkrekate and 
the inducing effects of atractylate [both selective 
inhibitors of adenine nucleotide translocase (ANT)] it 
has been suggested that the pore might be formed by 
the translocase itself [18]. Consistent with this hy- 
pothesis is the finding that the ANT reconstituted in 
giant liposomes exhibits a high conductance channel 
activity that is stimulated by Ca 2+, and displays the 
gating effects and voltage-dependence expected of 
the MTP [19]. On the other hand, the reconstituted 
ANT channel is not inhibited by cyclosporin A 
(CsA), the most selective MTP inhibitor described so 
far [3], while the ANT adopts very different con- 
formations in the presence of atractylate ('c' con- 
formation) or bongkrekate ('m' conformation) [20], 
which may in turn affect he MTP through changes of 
the surface potential (see Ref. [2] for discussion). 
Of interest is the finding that complexes prepared 
by extraction of mitochondria with low concentra- 
tions of detergent, and enriched in hexokinase, porin 
and ANT exhibit Ca2+-dependent a d CsA-sensitive 
high-conductance channel activity when reconstituted 
in planar lipid bilayers. This preparation also cata- 
lyzes Ca2+-dependent and CsA-sensitive ATP and 
malate diffusion after incorporation in proteolipo- 
somes [21]. It must be mentioned, however, that 
these fractions contain a number of other proteins, 
and that the most active among them were not 
enriched in ANT or porin but rather in a 67 kDa 
species that may be composed of heterodimers of 
these proteins [21 ]. 
A role for the outer membrane in the permeability 
transition is supported by the intriguing finding that 
overexpression f the bcl-2 protein (an antiapoptotic 
member of the bcl superfamily that largely localizes 
to the outer mitochondrial membrane [22]) appears to 
prevent induction of the permeability transition fol- 
lowing specific stimuli [13]. 
In general, it appears conceivable that the MTP is a 
complex and dynamic molecular structure comprising 
inner and outer membrane components, and that the 
ANT may either play a structural role in channel 
formation or a regulatory role in its open-closed 
transitions. It is also of interest that the MTP may be 
regulated by protein-protein i teractions from the 
matrix (cyclophilin D; CyP-D [23,24]), the inter- 
membrane space (creatine kinase [25]), and the outer 
membrane (hexokinase [21] and bcl-2 family mem- 
bers [13]). 
3. Mechanistic aspects of pore modulation 
The basic effectors of MTP modulation i  isolated 
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mitochondria (transmembrane voltage [26], matrix 
pH [8,27], divalent cations [28], CyP-D and CsA 
[23,24], pyridine nucleotides (PN) and glutathione 
[29,30]), and the consequences of the permeability 
transition on the integrity of the outer and inner 
membranes in vitro [31] have been summarized in 
previous reviews [2,32]. Here we will consider only 
recent advances and controversial issues, and illus- 
trate our current strategies aimed at a molecular 
definition of the permeability transition and of its 
function in cellular pathophysiology. 
3.1. Membrane potential 
The MTP behaves like a voltage-dependent chan- 
nel both in isolated mitochondria nd in single 
channel measurements of mitoplasts [3]. However, 
evidence that the pore is voltage dependent in 
mitochondria rested entirely on the effects of the 
protonophoric uncoupler carbonylcyanide-p-trifluoro- 
methoxyphenyl hydrazone (FCCP) [26,33]. Uncoup- 
lers can also increase the production of reactive 
oxygen species (ROS) (such as H202), particularly in 
the presence of antimycin A and after Ca 2+ accumu- 
lation [34]. Since ROS have long been implied in the 
permeability transition ( [35] and Refs. therein), it 
appeared essential to establish if membrane depolar- 
ization or rather ROS-dependent oxidative stress [36] 
is the link between FCCP and MTP opening. We have 
therefore carried out experiments under strict nitrogen 
anoxia, and observed MTP opening upon addition of 
FCCP despite the absence of ROS [37]. Furthermore, 
MTP opening could be observed after depolarization 
induced by K + currents, confirming that it indeed 
depends on depolarization rather than on an effect of 
FCCP as such [37]. 
The MTP voltage dependence implies the existence 
of a sensor that decodes the voltage changes into 
variations of the probability of pore opening. Since 
highly conserved arginine residues play a key role in 
voltage sensing by the plasma membrane K +, Na + 
and Ca 2+ channels [38], we are characterizing the 
properties of mitochondria modified with the rela- 
tively specific arginine reagents, phenylglyoxal and 
2,3 butanedione. Our results suggest hat arginine 
residues play a key role in modulation of pore 
opening by Ca 2+ and depolarization [39]. We are 
currently defining incubation conditions that should 
allow selective labeling with [~4C]phenylglyoxal of 
arginine residues that we suspect o be part of the 
MTP voltage sensing mechanism. 
3.2. Redox reactions and respiratory chain 
Complex I 
The MTP possesses two redox-sensitive sites that 
both increase the probability of opening after oxida- 
tion; (i) the 'S-site', a dithiol in apparent redox 
equilibrium with matrix glutathione; and (ii) the 'P- 
site', in apparent redox equilibrium with the PN pool 
[29,30]. It can therefore be predicted that the pore 
will be affected by changes of both the GSH/GSSG 
and NAD(P)H/NAD(P) + ratios. For no immediately 
obvious reason, the standard condition for mitochon- 
drial energization i  vitro is the combination of the 
Complex I inhibitor rotenone and the Complex II 
electron donor succinate. This condition profoundly 
affects: (i) the ability of mitochondria to deal with 
oxidative stress; and (ii) the consequences of MTP 
opening on respiration. 
(i) In isolated mitochondria, the main source of 
reducing equivalents for NADP + (essential to 
maintain a reduced GSH pool through gluta- 
thione reductase) is NADH through the activity 
of transhydrogenase, an inner membrane proton 
pump [40,41]. Oxidation of GSH (e.g., by tert- 
butylhydroperoxide) is readily followed by oxi- 
dation of NADPH and NADH. We found that 
with succinate as the substrate reduction of PN 
is only possible in the absence of rotenone, 
while in the presence of rotenone PN remained 
fully oxidized (E. Fontaine and P. Bernardi, 
unpublished observations). A key role of 
NADH as the source of reducing equivalents for 
mitochondrial antioxidant defenses through 
transhydrogenase i  supported by the finding 
that the redox-cycling agent paraquat induces 
MTP opening through GSH oxidation in suc- 
cinate-energized rat liver mitochondria only in 
the presence of rotenone, while it becomes 
totally ineffective when rotenone is omitted 
[42]. On the other hand, rotenone omission 
greatly sensitizes mitochondria to pore opening 
induced by FCCP (i.e. by depolarization with 
increased electron flow), with an effect that can 
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be largely attributed to the ensuing NAD(P)H 
oxidation and thus to MTP modulation at the 
P-site [29]. Thus, the presence of rotenone and 
Complex I respiratory substrates may either 
facilitate or prevent pore opening depending on 
the specific mechanism of induction. 
(ii) The consequences of pore opening on 
respiration critically depend on whether Com- 
plex I or II substrates are used. Oxidation of 
Complex I substrates relies on the availability 
of NAD +, and PN are readily lost at the onset 
of the permeability transition [29] resulting in 
complete respiratory inhibition [43-45]. On the 
other hand, with Complex II substrates respira- 
tion will proceed espite PN depletion, resulting 
in the typical uncoupling observed when the 
pore opens under these conditions. Since oxi- 
dized PN are rapidly degraded by intermem- 
brane glycohydrolase [46], we predict that the 
major consequence of pore opening in intact 
cells is respiratory inhibition rather than uncou- 
pling, due to disappearance of PN. This is not 
always appreciated when inferring the conse- 
quences of pore opening on cellular oxygen 
consumption [47]. 
Because of these outstanding problems, we have 
reinvestigated the effects of substrates on the per- 
meability transition. We made the intriguing discov- 
ery that pore opening is modulated by electron flux 
through respiratory chain Complex I with an effect 
that can be clearly discriminated from both NADH 
oxidation and membrane depolarization, and that 
does not depend on increased Ca 2- uptake or better 
membrane nergization. Increased electron flux was 
indeed accompanied by a marked inducing effect on 
the permeability transition, which could be coun- 
teracted by decreasing the flux through Complex I but 
not Complex III or IV [48]. 
3.3. CsA and CyP-D 
The permeability ransition is inhibited by submic- 
romolar concentrations of the immunosuppressant 
peptide CsA [2], but the mechanism of inhibition 
remains undefined. CyP-D is a matrix peptidyl prolyl 
cis-trans isomerase [49] whose enzymatic activity 
can be inhibited by CsA. CyP-D is the only CsA- 
binding protein that can be reproducibly purified from 
mitochondria by affinity chromatography on im- 
mobilized CsA [24]. Available data support a model 
where binding of CyP-D to the pore favors opening 
[23,50], and CsA causes pore closure through unbind- 
ing of CyP-D after formation of the CsA.CyP-D 
complex [24]. It remains unclear whether the peptidyl 
prolyl cis-trans isomerase activity of CyP-D is 
relevant for MTP modulation, and whether its inhibi- 
tion by CsA is relevant for MTP closure. 
Histidine residues play a major role in the modula- 
tion of the MTP by matrix H +. Histidine protonation 
indeed causes reversible MTP closure, and this effect 
can be prevented by the histidine reagent, dieth- 
ylpyrocarbonate [27]. We treated CyP-D with con- 
centrations of diethylpyrocarbonate that are effective- 
ly inducing MTP opening, and found that its en- 
zymatic activity was inhibited [51]. This finding 
suggests that the effects of CyP-D on the pore are 
probably independent of its activity as a peptidyl 
prolyl cis-trans isomerase. 
Rat CyP-D possesses five histidine residues [49]. 
In order to better understand their role in CyP-D 
function (and possibly in MTP modulation), we 
produced mutants by site-directed mutagenesis of the 
rat CyP-D cDNA. We found that a H167Q mutant of 
CyP-D (histidine 167 of CyP-D corresponds to 
histidine 125 of CyP-A, the cytosolic isoform, which 
is in close proximity to the CsA binding site [52] and 
is important for the enzyme activity [53]) displays a 
dramatically reduced peptidyl prolyl cis-trans iso- 
merase activity. Yet, the binding affinity for CsA was 
unchanged, as indicated by titrations with CsA of the 
activity of the wild type and of the residual activity of 
the mutant, and from binding to a CsA affinity matrix 
[54]. These data indicate that H16 7 is extremely 
important for binding of the substrate (and possibly 
the MTP) but not of CsA. Experiments are underway 
to test whether the H167Q mutant also displays lower 
binding affinity to inside-out submitochondrial par- 
ticles (which would be suggestive of a lower binding 
affinity to pore components, ee Ref. [24]). 
The creation of mice in which the expression of 
CyP-D has been eliminated by 'knock-out' tech- 
niques should unambiguously resolve basic questions 
concerning the mechanism of MTP inhibition by CsA 
and the influence, if any, of CyP-D on the permeabili- 
ty transition and possibly other mitochondrial func- 
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tions. The generation of such mice is currently 
underway. 
4. Release of cytochrome c and the permeability 
transition 
Isolated mitochondria can undergo in vitro swell- 
ing following basically two mechanisms; (i) energy- 
dependent cation (Na +, K +, Ca z+) uptake through 
selective channels; or (ii) energy-independent solute 
diffusion (ions or low MW sugars and metabolites) 
through the MTP. In both cases swelling is reversible, 
suggesting that it does not lead to inner membrane 
damage, while the outer membrane undergoes me- 
chanical disruption [55]. This in turn leads to release 
of cytochrome c if the experiment is performed in 
salt-based rather than sucrose-based media [31]. It 
must be stressed that cytochrome c release is in- 
dependent of the cause of swelling, and that sub- 
sequent addition of cytochrome c can restore respira- 
tion and therefore nergy-linked ion transport when 
succinate is the substrate. 
Release of intermembrane proteins (cytochrome c 
[11] and a mitochondrial caspase [13]) have been 
implicated in apoptosis. For the latter factor, opening 
of the MTP has been suggested as the underlying 
mechanism, while the mechanism of cytochrome c 
release has not been clarified. We are addressing the 
issue of whether cytochrome c release and/or in- 
activation [56] depend on swelling as such, or 
whether MTP opening can affect cytochrome c
function independent of rupture of the outer mito- 
chondrial membrane. Our preliminary results indicate 
that two conditions can be identified: (i) outer 
membrane rupture with release of cytochrome c but 
not of citrate synthase or other matrix proteins; and 
(ii) inhibition of respiration due to block of electron 
transfer at cytochrome c following pore opening in 
the absence of swelling (L. Scorrano and E Bernardi, 
unpublished results). We have now produced a green 
fluorescent protein-cytochrome c fusion construct 
that might allow validation of this model in intact 
living cells. 
5. Measurement of the MTP in intact cells 
The most widely used tool to detect MTP operation 
in intact cells is CsA-sensitive depolarization. It is 
clear, however, that lack of sensitivity to CsA does 
not rule out the occurrence of MTP opening. Indeed, 
even with isolated mitochondria the inhibitory effect 
of CsA is transient [57], and can be largely overcome 
by a variety of pore inducers of pathophysiological 
relevance like Ca 2+ itself. Furthermore, it is not clear 
whether CsA reaches mitochondria n pharmacologi- 
cally effective concentrations, while cellular CsA 
metabolism ay yield products that are ineffective at 
MTP inhibition like N-desmethyl-4-CsA [2]. Since 
no CyP-D-selective (MTP-selective) CsA derivatives 
are available, CsA will inevitably bind to other 
cyclophilins (CyP-A in the cytosol, and both CyP-A 
and CyP-B in the endoplasmic reticulum). Finally the 
MTP could play a key role in mitochondrial Ca 2+ 
homeostasis [9], and MTP inhibition by CsA might 
therefore cause unpredictable effects (including depo- 
larization) due to mitochondrial Ca 2+ overload. 
These limitations demand the development of 
reliable tools to measure MTP opening in intact cells, 
independent of the changes in membrane potential. 
We used calcein-AM loading of intact cells, followed 
by selective quenching of the fluorescence signal in 
the cytosol by treatment with low concentrations of
Co 2+. In these protocols, mitochondria re brightly 
fluorescent over a dark background, and pore opening 
can be monitored as the decrease of mitochondrial 
fluorescence over time of incubation due to calcein 
efflux. Our results indicate that the MTP opens 
transiently even in the absence of inducers [58], 
suggesting that it might be responsible for the 
spontaneous transient mitochondrial depolarizations 
observed in intact cells [59]. 
6. Conclusions and perspectives 
In this short review we have summarized our 
current views on the mitochondrial permeability 
transition and on our strategies to resolve some of the 
outstanding issues about its nature and function. In 
general, it appears that the renewed enthusiasm in the 
role of mitochondria in cellular life and death is 
largely justified. On the other hand, it is also clear 
that most of the proposed links between the per- 
meability transition and cell death should be consid- 
ered more as exciting working hypotheses that need 
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experimental scrutiny than as established facts. Pro- 
gress can only come from a multidisciplinary effort, 
however, and we have little doubt that the next few 
years will see a fundamental increase in our under- 
standing of the mechanistic aspects of mitochondrial 
involvement in cell death. 
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